Bristol-Myers Squibb | BMY - Ebit

Stock Price
56.67
Daily Change
0.68 1.21%
Monthly
6.80%
Yearly
-4.14%
Q1 Forecast
53.35

Bristol-Myers Squibb reported $4.04B in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Abbott USD 2.54B 358M Dec/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 34.08B 4.71B Jun/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sanofi EUR 3.74B 2.23B Sep/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Zoetis USD 975M 40M Sep/2025